RecruitingNCT07679581

Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4

Cannabis and Memory


Sponsor

L. Cinnamon Bidwell

Enrollment

64 participants

Start Date

Dec 10, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.


Eligibility

Min Age: 21 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Cannabis (smoked flower) for people with cannabis, electroencephalography, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCannabis (smoked flower)

Self directed use (ad libitum)


Locations(1)

Center for Innovation and Creativity (CINC)

Boulder, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07679581


Related Trials